Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 2 | Molecular Cancer

Figure 2

From: Synergistic antitumor activity of oncolytic reovirus and chemotherapeutic agents in non-small cell lung cancer cells

Figure 2

Levels of GTP-bound activated Ras protein in 9 NSCLC cell lines analyzed by Western blot, using anti-pan-Ras antibody. Note, high levels of activated Ras were observed with A549/ATCC (K-rasG12S) [13], HOP-62 (K-rasG12C) [13], and NCI-H23 (K-rasG12C) [13], followed by NCI-H460 (K-rasQ61H) [13], EKVX and HOP-92. The levels of activated Ras were significantly lower not only with ReoT3D-resistant NCI-H322M and NCI-H226, but also with ReoT3D sensitive cell line, NCI-H522. Also see table 1 for comparison of Ras-activating gene mutation status and ReoT3D sensitivity of each cell line.

Back to article page